Randomised, placebo-controlled, relapse-prevention study with once-daily quetiapine sustained release in patients with schizophrenia

被引：0
|
作者：
Peuskens, J.
Trivedi, J. K.
Malyarov, S.
Brecher, M.
Svensson, O.
Miller, F.
Persson, I.
Meulien, D.
机构：
[1] Univ Psychiat Centrum KU Leuven, Kortenberg, Belgium
[2] King George Med Univ, Lucknow, Uttar Pradesh, India
[3] Kyiv Psychoneurol Hosp, Kiev, Ukraine
[4] AstraZeneca, Wilmington, DE USA
[5] AstraZeneca R&D, Sodertalje, Sweden
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] A randomized,placebo-controlled,relapse-prevention study with oncedaily quetiapine sustained release in patients with schizophrenia
    Peuskens, J. C.
    Trivedi, J. K.
    Malyarov, S.
    Brecher, M.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 453 - 453
  • [2] Efficacy and tolerability of once-daily quetiapine sustained release in patients with acute schizophrenia: A randomised, double-blind, 6-week, placebo-controlled study
    Kahn, R.
    Schulz, C.
    Palazov, V.
    Reyes, E.
    Meulien, D.
    Brecher, M.
    Svensson, O.
    Andersson, H. M.
    EUROPEAN PSYCHIATRY, 2007, 22 : S118 - S118
  • [3] Efficacy and tolerability of once-daily quetiapine sustained release in patients with acute schizophrenia: A randomised, double-blind, 6-week, placebo-controlled study
    Kahn, Rene
    Schulz, C.
    Palazov, V.
    Reyes, E.
    Meulien, D.
    Brecher, M.
    Svensson, O.
    Andersson, H. M.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 262S - 262S
  • [4] A randomised, placebo-controlled study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 332 - 333
  • [5] Clinical benefit of switching patients with schizophrenia to once-daily quetiapine sustained release
    Ganesan, S.
    Agambarant, V.
    Randeree, F.
    Eggens, I.
    Schmidt, M. M.
    Meulien, D.
    EUROPEAN PSYCHIATRY, 2007, 22 : S334 - S335
  • [6] Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled study
    Kahn, Rene S.
    Schulz, S. Charles
    Palazov, Veselin D.
    Reyes, Efren B.
    Brecher, Martin
    Svensson, Ola
    Andersson, Henrik M.
    Meulien, Didier
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 832 - 842
  • [7] TOLERABILITY OF ONCE-DAILY EXTENDED RELEASE QUETIAPINE COMPARED TO QUETIAPINE IMMEDIATE RELEASE: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS IN SCHIZOPHRENIA
    Edwards, S. J.
    Korim, F.
    VALUE IN HEALTH, 2008, 11 (06) : A582 - A582
  • [8] Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies
    Meulien, Didier
    Huizar, Karin
    Brecher, Martin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (02) : 103 - 115
  • [9] Once-daily extended release quetiapine fumarate (quetiapine xr): Pooled safety data from 3 placebo-controlled monotherapy studies in acute schizophrenia
    Meulien, D.
    Brecher, M.
    Huizar, K.
    EUROPEAN PSYCHIATRY, 2008, 23 : S132 - S132
  • [10] Subgroup analysis of Malaysian patients in a randomised, placebo-controlled relapse-prevention study with escitalopram in obsessive-compulsive disorder
    Said, M. A.
    Sulaiman, A. H.
    Yen, Th.
    Noor, M. A. Mohd
    Lemming, O. M.
    Zain, A. Md
    Jambunathan, S. T.
    Gill, J. S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 282 - 283
12345